Table 4.

Medication use at baseline and end-of-study.

Medication use	Intervention		Control
	Baseline	End-of-study	Baseline	End-of-study
Blood pressure medications	3 (5.3)	4 (7.7)	1 (1.6)	3 (5.7)
Lipid lowering medications	1 (1.8)	0 (0.0)	0 (0.0)	0 (0.0)
Anti-platelet therapy	1 (1.8)	0 (0.0)	0 (0.0)	0 (0.0)
Glucose lowering medications	11 (19.3)	10 (19.2)	8 (12.7)	6 (11.3)
Tuberculosis medications
Intensive phase	31 (54.4)	0 (0.0)	37 (58.7)	0 (0.0)
Continuation phase	26 (45.6)	0 (0.0)	25 (39.7)	0 (0.0)
Anti-retroviral therapy	2 (3.5)	0 (0.0)	3 (4.8)	2 (3.8)

Values are mentioned as number (%).